GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (NAS:HSIC) » Definitions » ROE %
中文

Henry Schein (Henry Schein) ROE % : 1.97% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Henry Schein ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Henry Schein's annualized net income for the quarter that ended in Dec. 2023 was $72 Mil. Henry Schein's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $3,653 Mil. Therefore, Henry Schein's annualized ROE % for the quarter that ended in Dec. 2023 was 1.97%.

The historical rank and industry rank for Henry Schein's ROE % or its related term are showing as below:

HSIC' s ROE % Range Over the Past 10 Years
Min: 11.7   Med: 16.74   Max: 23.32
Current: 11.7

During the past 13 years, Henry Schein's highest ROE % was 23.32%. The lowest was 11.70%. And the median was 16.74%.

HSIC's ROE % is ranked better than
71.58% of 95 companies
in the Medical Distribution industry
Industry Median: 7.24 vs HSIC: 11.70

Henry Schein ROE % Historical Data

The historical data trend for Henry Schein's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henry Schein ROE % Chart

Henry Schein Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.32 12.73 18.63 15.66 11.72

Henry Schein Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 13.99 15.93 15.20 1.97

Competitive Comparison of Henry Schein's ROE %

For the Medical Distribution subindustry, Henry Schein's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henry Schein's ROE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Henry Schein's ROE % distribution charts can be found below:

* The bar in red indicates where Henry Schein's ROE % falls into.



Henry Schein ROE % Calculation

Henry Schein's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=416/( (3446+3655)/ 2 )
=416/3550.5
=11.72 %

Henry Schein's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=72/( (3651+3655)/ 2 )
=72/3653
=1.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Henry Schein  (NAS:HSIC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=72/3653
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(72 / 12068)*(12068 / 10191.5)*(10191.5 / 3653)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.6 %*1.1841*2.7899
=ROA %*Equity Multiplier
=0.71 %*2.7899
=1.97 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=72/3653
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (72 / 56) * (56 / 240) * (240 / 12068) * (12068 / 10191.5) * (10191.5 / 3653)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.2857 * 0.2333 * 1.99 % * 1.1841 * 2.7899
=1.97 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Henry Schein ROE % Related Terms

Thank you for viewing the detailed overview of Henry Schein's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Henry Schein (Henry Schein) Business Description

Traded in Other Exchanges
Address
135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Executives
Stanley M Bergman director, officer: President and CEO C/O HENRY SCHEIN INC, 135 DURYEA ROAD, MELVILLE NY 11747
Bradford C Connett officer: CEO, NA Distribution Group C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Brous David B Jr officer: CEO, Strategic Business Group C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Walter Siegel officer: Senior VP & General Counsel C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
James P Breslawski director, officer: Executive Vice President C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Michael S Ettinger officer: SVP, General Counsel, Sec. C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Mark E Mlotek director, officer: SVP, Corp Bus Dev Group C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Lorelei Mcglynn officer: SVP, Global HR & Fin. Oper. C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Gerald A Benjamin director, officer: Executive V.P and CAO C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
Ronald N. South officer: SVP & Chief Financial Officer C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Philip A Laskawy director 9 CREAMER HILL ROAD, GREENWICH CT 06831
Kurt P Kuehn director C/O HENRY SCHEIN, INC, 135 DURYEA ROAD, MELVILLE NY 11747
Scott Philip Serota director C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Reed Vaughn Tuckson director C/O UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST, MINNETONKA MN 55123
Steven Paladino director, officer: Executive V.P. and CFO C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747

Henry Schein (Henry Schein) Headlines